The company said it will release its Q1 2025 financial results before the market opens on Tuesday, April 29, 2025. It will host a conference call and webcast beginning at 9 a.m. ET that day.

8-KRegulation FD DisclosureFiled Mar 31, 2025Period of report Mar 31, 2025Summary published (UTC) Oct 15, 2026

Key points

AI summary

The company said it will release its Q1 2025 financial results before the market opens on Tuesday, April 29, 2025. It will host a conference call and webcast beginning at 9 a.m. ET that day.
Labcorp said it will post the earnings press release and related financial information on its Investor Relations website. The conference call will be webcast live on that website.
The company said the webcast and dial-in are listen-only and recommended that participants join 10 minutes before the start. A replay will be available about 2 hours after the live event ends, through April 16, 2026.
The company described itself in its press release as having nearly 70,000 employees serving clients in approximately 100 countries. It said it performs more than 700 million tests annually and supported more than 75% of the new drugs and therapeutic products approved by the FDA in 2024.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Q1 2025 Earnings Release Schedule

The company said it will release its Q1 2025 financial results before the market opens on Tuesday, April 29, 2025. It will host a conference call and webcast beginning at 9 a.m. ET that day.

Source · Based on the filing body and exhibits

Earnings Materials Posting

Labcorp said it will post the earnings press release and related financial information on its Investor Relations website. The conference call will be webcast live on that website.

Source · Based on the filing body and exhibits

Webcast Access and Replay Information

The company said the webcast and dial-in are listen-only and recommended that participants join 10 minutes before the start. A replay will be available about 2 hours after the live event ends, through April 16, 2026.

Source · Based on the filing body and exhibits

Company Profile Scale

The company described itself in its press release as having nearly 70,000 employees serving clients in approximately 100 countries. It said it performs more than 700 million tests annually and supported more than 75% of the new drugs and therapeutic products approved by the FDA in 2024.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.